Aranesp ® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on dialysis and not on dialysis.

Aranesp® is a prescription medication that is used to treat anemia by helping the body create more red blood cells.

Aranesp ® reduced the need for red blood cell (RBC) transfusion vs placebo 1, 2 EOTP = end of trial period; QW = once weekly. Data from a randomized, double-blind, placebo-controlled trial of 314 …

Aranesp ® is the only long-acting erythropoiesis-stimulating agent (ESA) approved for both once weekly (QW) and once every three weeks (Q3W) dosing 1, 2 Aranesp ® dosing options of QW or Q3W may …

Aranesp ® reduced the need for red blood cell (RBC) transfusion vs placebo by 48% 1, 3,† † Data from a double-blind, placebo-controlled, randomized study of lung cancer patients receiving chemotherapy.

Aranesp ® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on dialysis and not on dialysis.

Find additional resources, including Aranesp® patient brochure, prescribing information, medication guide, and instructions for use.

Aranesp ® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on dialysis and not on dialysis.

Indication Aranesp® is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy, and upon …

Talk to your doctor or nurse about the possibility of anemia before beginning treatment with chemotherapy. * * Chemotherapy that will be used for at least two months after starting Aranesp ®.